Short-term study of rTMS for migraine prevention

This is a clinical trial of the medical device Migraine Guard Pro, which is under development. It is intended to study the positive short-term effects for the treatment of migraine.

Research has shown that the stimulation protocol used by Migraine Guard Pro can prevent more than 50% of migraine attacks*.

The study will be conducted at the Vivea Gesundheitshotel Bad Vöslau (Badner Straße 7-9, 2540 Bad Vöslau)**.

NOTE: This is not a binding registration for participating in the study, but a consent to recieve for information.

Please enable JavaScript in your browser to complete this form.
Have you been diagnosed with migraine by a doctor?
I am ready to travel to Bad Vöslau (close to Vienna) for the study.
How did you find out about us?
Data Consent

*Cheng et al. (2022),